Evidence map›Paper›PMID 41097798›Full record

ReviewCancers2025

Immune Checkpoint Inhibitors in Merkel Cell Carcinoma of the Skin: A 2025 Comprehensive Review.

Patricia Tai, Omar Alqaisi, Suhair Al-Ghabeesh, Lorent Sijarina, Edward Yu, Aoife Jones Thachuthara, Avi Assouline, Osama Souied, Kimberly Hagel, Kurian Joseph

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Radiotherapy for Merkel cell carcinoma: recommendations from the DEGRO Dermatooncology Working Group.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patricia TaiOncology Department, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada.ORCID 0000-0001-7700-776X
Omar AlqaisiNursing Department, Al-Zaytoonah University, Amman P.O. Box 130, Jordan.ORCID 0009-0006-9760-651X
Suhair Al-GhabeeshNursing Department, Al-Zaytoonah University, Amman P.O. Box 130, Jordan.ORCID 0000-0002-8345-0140
Lorent SijarinaFaculty of Medicine, University of Prishtina, 10000 Prishtina, Kosovo.ORCID 0009-0000-9309-9959
Edward YuOncology Department, Western University, London, ON N6A 3K7, Canada.ORCID 0000-0002-2900-115X
Aoife Jones ThachutharaMedical Oncology Department, Cork University, T12 K8AF Cork, Ireland.
Avi AssoulineOncology Department, Collège de Médecine des Hôpitaux de Paris, Cedex 12, 75 610 Paris, France.
Osama SouiedOncology Department, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada.
Kimberly HagelOncology Department, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada.
Kurian JosephOncology Department, University of Alberta, Edmonton, AB T6G 2R3, Canada.ORCID 0000-0003-3514-2183

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical trialsimmune checkpoint inhibitorimmunotherapyMerkel cell carcinomaPRISMArecommendationsreviewskin cancersystemic therapy

Identifiers

PMID41097798
PMCPMC12523286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.